Indicated for: HIV-1 infection
Route of administration: oral
Substance: efavirenz (non-nucleoside reverse transcriptase inhibitor)
ATC: J05AG03 (Antiinfectives for systemic use | Direct acting antivirals | Non-nucleoside reverse transcriptase inhibitors)
Efavirenzum is an antiretroviral medication used for the treatment of HIV-1 infection. It belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and works by blocking the enzyme necessary for HIV replication.
The medication is taken orally, usually once daily, in combination with other antiretroviral drugs, according to the doctor's instructions. It is effective in reducing viral load and increasing CD4 cell count.
Side effects may include dizziness, insomnia, rash, nausea, and, in rare cases, psychiatric disorders or hepatotoxicity. Regular monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Efavirenzum. Follow the prescribed dosage and adhere to all medical recommendations.